Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.5B | 3.0B | 2.8B | 2.6B |
Cost of revenue | 1.2B | 1.5B | 1.4B | 1.3B |
Gross profit | 1.3B | 1.5B | 1.4B | 1.3B |
Operating expense | ||||
Research & development | 233M | 246M | 234M | 220M |
Selling general and admin | 436M | 487M | 439M | 430M |
Other operating expenses | — | — | — | — |
Operating income | 594M | 776M | 722M | 653M |
Non operating interest income | ||||
Income | 18M | 18M | 15M | 18M |
Expense | 69M | 74M | 73M | 87M |
Other income expense | 4M | 68M | 31M | -4M |
Pretax income | 547M | 788M | 695M | 580M |
Tax provision | 115M | 176M | 132M | 135M |
Net income | 432M | 612M | 563M | 445M |
Basic EPS | 2.6 | 3.7 | 3.4 | 2.7 |
Diluted EPS | 2.5 | 3.6 | 3.3 | 2.6 |
Basic average shares | 166.9M | 167.1M | 167.1M | 166.9M |
Diluted average shares | 169.8M | 171.4M | 170.9M | 170.3M |
EBITDA | 716M | 912M | 858M | 761M |
Net income from continuing op. | 432M | 612M | 563M | 445M |
Minority interests | -2M | -1M | -1M | -2M |
Preferred stock dividends | — | — | — | — |